SCHEMBL462694

SCHEMBL462694

Cc1cc(C(CC(=O)O)c2cc(C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.49
CYP2C19 P33261 5/20 0.49
CYP1A2 P05177 3/20 0.49
GLRA3 O75311 1/20 0.43
GLRB P48167 1/20 0.43
CACNA1A O00555 1/20 0.41
CACNA2D1 P54289 1/20 0.41
CACNB1 Q02641 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
CA2 P00918 2/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
TYR P14679 1/20 0.40
GPR55 Q9Y2T6 1/20 0.38
CYP2D6 P10635 3/20 0.38
MEN1 O00255 1/20 0.38
GALR3 O60755 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4428292 0.90 GLRA3 (0.48) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL5567888 0.88 CYP2C9 (0.46) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL28233331 0.85 CYP2C9 (0.44) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL10920962 0.82 CYP1A2 (0.41) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL11327008 0.81 CYP2C9 (0.53) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL7257754 0.81 CYP2C9 (0.53) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL2474153 0.81 CYP1A2 (0.40) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL11689866 0.80 CYP2C9 (0.52) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL9007959 0.80 CYP2C9 (0.52) CYP2C9CYP2C19CYP1A2GLRA3GLRB
SCHEMBL16673217 0.80 CYP2C9 (0.39) CYP2C9CYP2C19CYP1A2GLRA3GLRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2840112-B1 Stabilized polymer compositions and methods of making same BAERLOCHER GMBH (DE) 2019-04-10 EP claimed
EP-2927263-B1 Polyamide moulding compositions, in particular for manufacturing moulded parts in the drinking water sector EMS PATENT AG (CH) 2016-03-09 EP claimed
US-8859690-B2 Biodegradable composite, the preparation process thereof, and a disposable article made therefrom CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2014-10-14 US claimed
US-20120329924-A1 Biodegradable Composite, The Preparation Process Thereof, And A Disposable Article Made Therefrom BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2012-12-27 US claimed
EP-1115797-B1 PHOTOPOLYMERIZABLE ACRYLIC LACQUER COMPOSITIONS BASF COATINGS AG (DE) 2009-07-01 EP claimed
US-20260071046-A1 METHODS OF MAKING POLYVINYL CYCLOHEXANE VIA HYDROGENATION OF WASTE POLYSTYRENE SOURCES SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2026-03-12 US disclosed
US-12570848-B2 Scratch-resistant high impact strength PMMA compositions SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2026-03-10 US disclosed
EP-4110849-B1 HIGH HEAT POLYCARBONATE COPOLYMER FORMULATIONS SHPP GLOBAL TECH BV (NL) 2025-12-24 EP disclosed
EP-4626975-A1 CHROMIUM ACID ETCHING FREE METAL PLATING OF BLENDS OF ACRYLONITRILE-BUTADIENE-STYRENE AND POLAR POLYMER SABIC Global Technologies B.V. (NL) 2025-10-08 EP disclosed
EP-4590727-A1 METHODS OF MAKING POLYVINYL CYCLOHEXANE VIA HYDROGENATION OF WASTE POLYSTYRENE SOURCES SABIC Global Technologies B.V. (NL) 2025-07-30 EP disclosed
EP-4172269-B1 THERMOPLASTIC COMPOSITIONS WITH IMPROVED HYDROLYTIC AND HEAT STABILITY SHPP GLOBAL TECH BV (NL) 2025-05-28 EP disclosed
US-20250019503-A1 METAL COMPLEXED CYANURATE GERMICIDAL ADDITIVE FOR POLYMER COMPOSITIONS SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2025-01-16 US disclosed
US-10093796-B2 Resin composition and molded body MIDORI ANZEN CO., LTD. (JP) 2018-10-09 US disclosed
EP-3347393-A1 SCRATCH-RESISTANT TWO-COMPONENT POLYURETHANE COATINGS Covestro Deutschland AG (DE) 2018-07-18 EP disclosed
US-20120065306-A1 LONG-FIBER REINFORCED RESIN COMPOSITION AND MOLDED OBJECT THEREOF PRIME POLYMER CO., LTD. (JP) 2012-03-15 US disclosed
EP-0609061-B1 Polymerizable composition, polymer, organic glass and ophthalmic lens TOKUYAMA CORP (JP) 1999-09-29 EP disclosed
US-5789470-A PIPERIDINE COMPOUNDS AS STABILIZERS FOR MACROCYCLIC TRIAZINES CIBA SPECIALTY CHEMICALS CORPORATION (US) 1998-08-04 US disclosed
EP-0812882-A1 LONG-FIBERGLASS REINFORCED POLYOLEFIN MOLDINGS IMPROVED IN WEATHERING RESISTANCE AND COMPOSITIONS USEFUL AS THE RAW MATERIAL THEREFOR KAWASAKI STEEL CORPORATION (JP) 1997-12-17 EP disclosed
US-5475074-A Copolamerizable monomers containing vinyl benzyl compound, 2,4-diphenyl-4-methyl-1-pentene and an acrylic momomer; also contains mercapto, hindered phenol and azo compounds; high refractive index, heat and radiation resistance TOKUYAMA CORPORATION (JP) 1995-12-12 US disclosed
EP-0609061-A2 Polymerizable composition, polymer, organic glass and ophthalmic lens TOKUYAMA CORPORATION (JP) 1994-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250019503-A1 METAL COMPLEXED CYANURATE GERMICIDAL ADDITIVE FOR POLYMER COMPOSITIONS AP3M1, ACR, MPO CYP2C9 2712/4885CYP2C19 2943/4885CYP1A2 3013/4885
US-20260071046-A1 METHODS OF MAKING POLYVINYL CYCLOHEXANE VIA HYDROGENATION OF WASTE POLYSTYRENE SOURCES HTT, VHL, PARG CYP2C9 2202/4885CYP2C19 2798/4885CYP1A2 2723/4885
US-12570848-B2 Scratch-resistant high impact strength PMMA compositions PCNA, COL2A1, COL1A1 CYP2C9 2544/4885CYP2C19 1794/4885CYP1A2 3495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.